232 related articles for article (PubMed ID: 28472073)
21. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
Halin S; Wikström P; Rudolfsson SH; Stattin P; Doll JA; Crawford SE; Bergh A
Cancer Res; 2004 Aug; 64(16):5664-71. PubMed ID: 15313905
[TBL] [Abstract][Full Text] [Related]
22. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
23. Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases.
Morgat C; Chastel A; Molinie V; Schollhammer R; Macgrogan G; Vélasco V; Malavaud B; Fernandez P; Hindié E
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959962
[TBL] [Abstract][Full Text] [Related]
24. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
25. Factors in prostate cancer metastasis.
Geldof AA; Rao BR
Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
[TBL] [Abstract][Full Text] [Related]
26. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.
Momma T; Hamblin MR; Wu HC; Hasan T
Cancer Res; 1998 Dec; 58(23):5425-31. PubMed ID: 9850075
[TBL] [Abstract][Full Text] [Related]
28. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.
Halin S; Rudolfsson SH; Van Rooijen N; Bergh A
Neoplasia; 2009 Feb; 11(2):177-86. PubMed ID: 19177202
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
Jennbacken K; Vallbo C; Wang W; Damber JE
Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
[TBL] [Abstract][Full Text] [Related]
30. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?
Cheng L; Leibovich BC; Bergstralh EJ; Scherer BG; Pacelli A; Ramnani DM; Zincke H; Bostwick DG
Cancer; 1999 Jun; 85(11):2455-9. PubMed ID: 10357418
[TBL] [Abstract][Full Text] [Related]
31. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model.
Kovar JL; Johnson MA; Volcheck WM; Chen J; Simpson MA
Am J Pathol; 2006 Oct; 169(4):1415-26. PubMed ID: 17003496
[TBL] [Abstract][Full Text] [Related]
32. Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy.
Minardi D; Galosi AB; Giannulis I; Montironi R; Polito M; Muzzonigro G
Scand J Urol Nephrol; 2004; 38(1):19-25. PubMed ID: 15204422
[TBL] [Abstract][Full Text] [Related]
33. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L
Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal 3.0T MRI analysis of changes in lymph node volume and apparent diffusion coefficient in an experimental animal model of metastatic and hyperplastic lymph nodes.
Klerkx WM; Geldof AA; Heintz AP; van Diest PJ; Visser F; Mali WP; Veldhuis WB
J Magn Reson Imaging; 2011 May; 33(5):1151-9. PubMed ID: 21509874
[TBL] [Abstract][Full Text] [Related]
35. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
36. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
[TBL] [Abstract][Full Text] [Related]
37. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
38. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
39. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
40. Metastatic prostate cancer presenting as an asymptomatic neck mass.
Carleton J; van der Riet P; Dahm P
Prostate Cancer Prostatic Dis; 2005; 8(3):293-5; discussion 295. PubMed ID: 15897914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
